Learn how Computational Methods can accelerate biotech growth.
OpenEye Cadence Molecular Sciences is an industry leader in computational molecular design through rapid, robust, and scalable software, toolkits, technology and design services, and Orion®, the only cloud-native fully integrated software-as-a-service molecular modeling platform.
OpenEye is holding a biotechnology event to discuss how computational methods and software can accelerate your drug discovery project by growing and advancing your strategy. Early-stage planning can aid with raising venture capital.
Wednesday, September 27, 2023
6 - 9 p.m. Eastern Daylight Time
The Royal Sonesta Boston Hotel
40 Edwin Land Blvd.
Cambridge, Mass. 02142
6 - 7 p.m. Cocktails, hors d'oeuvres, and networking
7 - 8 p.m. Presentations
8 - 9 p.m. Cocktails, hors d'oeuvres, and conversation
Pat Walters, PhD, Chief Data Officer of Relay Therapeutics
As Chief Data Officer, Pat Walters oversees the development and application of the computational components of Relay Therapeutics’ Dynamo™ platform. Prior to joining Relay Therapeutics, he spent more than 20 years at Vertex Pharmaceuticals where he was global head of modeling and informatics. Pat is co-author of the book “Deep Learning for the Life Sciences,” published by O’Reilly and Associates. He is a member of the editorial board for Artificial Intelligence in the Life Sciences and is on the editorial advisory boards of The Journal of Medicinal Chemistry and The Journal of Chemical Information and Modeling.
Pat received his B.S. in chemistry from the University of California, Santa Barbara and his Ph.D. in organic chemistry from the University of Arizona, where he studied the application of artificial intelligence in conformational analysis. Prior to obtaining his Ph.D., he worked at Varian Instruments as both a chemist and a software developer.
Dr. Walters will present, "The Many Roles of Computation in Drug Discovery."
Paul Hawkins, PhD, Senior Scientific Product Evangelist, OpenEye Cadence Molecular Sciences
Dr. Hawkins obtained his undergraduate degree at the University of Southampton, his Ph.D. at the University of St. Andrews, and carried out post-doctoral work at Pennsylvania State University and the Australian National University. Paul then went into biotech as a medicinal chemist, working on a variety of projects in antibacterials, immunology, and oncology before joining the computational chemistry community as an applications scientist, first at Tripos/Certara and then at OpenEye. After over 15 years in various roles at OpenEye, Paul went back to biotech as a computational chemist, then returned to OpenEye in 2023 as their Product Evangelist.
Paul’s main areas of endeavor at OpenEye are conformer generation, shape-based methods in virtual screening and lead hopping, and the application of statistical approaches to method validation.
The free event will include cocktails and appetizers, the presentations, and a time for discussion afterward. You must be registered to attend. Register now!